|
1
|
Thun MJ, DeLancey JO, Center MM, Jemal A
and Ward EM: The global burden of cancer: Priorities for
prevention. Carcinogenesis. 31:100–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Suh DH, Kim JW, Aziz MF, Devi UK, Ngan HY,
Nam JH, Kim SC, Kato T, Ryu HS, Fujii S, et al: Asian Society of
Gynecologic Oncology Workshop 2010. J Gynecol Oncol. 21:137–150.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boyce JG, Fruchter RG, Nicastri AD, DeRegt
RH, Ambiavagar PC, Reinis M, Macasaet MA and Rotman M: Vascular
invasion in stage I carcinoma of the cervix. Cancer. 53:1175–1180.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zreik TG, Chambers JT and Chambers SK:
Parametrial involvement, regardless of nodal status: A poor
prognostic factor for cervical cancer. Obstet Gynecol. 87:741–746.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Delgado G, Bundy B, Zaino R, Sevin BU,
Creasman WT and Major F: Prospective surgical-pathological study of
disease-free interval in patients with stage IB squamous cell
carcinoma of the cervix: A Gynecologic Oncology Group study.
Gynecol Oncol. 38:352–357. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sevin BU, Lu Y, Bloch DA, Nadji M, Koechl
OR and Averette HE: Surgically defined prognostic parameters in
patients with early cervical carcinoma. A multivariate survival
tree analysis. Cancer. 78:1438–1446. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kamura T, Tsukamoto N, Tsuruchi N, Saito
T, Matsuyama T, Akazawa K and Nakano H: Multivariate analysis of
the histopathologic prognostic factors of cervical cancer in
patients undergoing radical hysterectomy. Cancer. 69:181–186. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Piver MS and Chung WS: Prognostic
significance of cervical lesion size and pelvic node metastases in
cervical carcinoma. Obstet Gynecol. 46:507–510. 1975.PubMed/NCBI
|
|
10
|
Estape RE, Angioli R, Madrigal M, Janicek
M, Gomez C, Penalver M and Averette H: Close vaginal margins as a
prognostic factor after radical hysterectomy. Gynecol Oncol.
68:229–232. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peters WA III, Liu PY, Barrett RJ II,
Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr and
Alberts DS: Concurrent chemotherapy and pelvic radiation therapy
compared with pelvic radiation therapy alone as adjuvant therapy
after radical surgery in high-risk early-stage cancer of the
cervix. J Clin Oncol. 18:1606–1613. 2000.PubMed/NCBI
|
|
12
|
Quinn MA, Benedet JL, Odicino F,
Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY and
Pecorelli S: Carcinoma of the cervix uteri. FIGO 26th Annual Report
on the Results of Treatment in Gynecological Cancer. Int J Gynaecol
Obstet. 95(Suppl 1): S43–S103. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Uno T, Ito H, Itami J, Yasuda S, Isobe K,
Hara R, Sato T, Minoura S, Shigematsu N and Kubo A: Postoperative
radiation therapy for stage IB-IIB carcinoma of the cervix with
poor prognostic factors. Anticancer Res. 20:2235–2239.
2000.PubMed/NCBI
|
|
14
|
Inoue T and Morita K: The prognostic
significance of number of positive nodes in cervical carcinoma
stages IB, IIA and IIB. Cancer. 65:1923–1927. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aoki Y, Sasaki M, Watanabe M, Sato T,
Tsuneki I, Aida H and Tanaka K: High-risk group in node-positive
patients with stage IB, IIA and IIB cervical carcinoma after
radical hysterectomy and postoperative pelvic irradiation. Gynecol
Oncol. 77:305–309. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lai CH, Chang HC, Chang TC, Hsueh S and
Tang SG: Prognostic factors and impacts of adjuvant therapy in
early-stage cervical carcinoma with pelvic node metastases. Gynecol
Oncol. 51:390–396. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park TK, Kwon JY, Kim SW, Kim SH, Kim SN
and Kim GE: Patterns of treatment failure following radiotherapy
with combination chemotherapy for patients with high-risk stage IIB
cervical carcinoma. Int J Clin Oncol. 9:120–124. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sakuragi N, Satoh C, Takeda N, Hareyama H,
Takeda M, Yamamoto R, Fujimoto T, Oikawa M, Fujino T and Fujimoto
S: Incidence and distribution pattern of pelvic and paraaortic
lymph node metastasis in patients with stages IB, IIA and IIB
cervical carcinoma treated with radical hysterectomy. Cancer.
85:1547–1554. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bonomi P, Blessing J, Ball H, Hanjani P
and DiSaia PJ: A phase II evaluation of cisplatin and
5-fluorouracil in patients with advanced squamous cell carcinoma of
the cervix: A Gynecologic Oncology Group study. Gynecol Oncol.
34:357–359. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Omura GA: Chemotherapy for stage IVB or
recurrent cancer of the uterine cervix. J Natl Cancer Inst Monogr.
123–126. 1996.PubMed/NCBI
|
|
21
|
Green JA, Kirwan JM, Tierney JF, Symonds
P, Fresco L, Collingwood M and Williams CJ: Survival and recurrence
after concomitant chemotherapy and radiotherapy for cancer of the
uterine cervix: A systematic review and meta-analysis. Lancet.
358:781–786. 2001. View Article : Google Scholar : PubMed/NCBI
|
